Search results for "Cardiovascular diseases."

showing 10 items of 2156 documents

Intrahematomal Ultrasound Enhances RtPA-Fibrinolysis in a Porcine Model of Intracerebral Hemorrhage

2021

Catheter-based ultrasound-thrombolysis has been successfully used in a small clinical trial in order to enhance recombinant tissue plasminogen activator (rtPA)-fibrinolysis, for the treatment of spontaneous intracerebral hemorrhages (ICHs). The aim of this study was to investigate the ultra-early effects of ultrasound on hematoma and the surrounding brain tissue in a porcine ICH-model. To achieve this, 21 pigs with a right frontal ICH were randomly assigned to four groups: (1) drainage (n = 3), (2) drainage + rtPA (n = 6), (3) drainage + ultrasound (n = 6), and (4) drainage + ultrasound + rtPA (n = 6). The hematoma volume assessment was performed using cranial MRI before and after the treat…

medicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyArticle03 medical and health sciences0302 clinical medicineHematomaEdemartPA-fibrinolysisFibrinolysismedicineminimally invasive therapycardiovascular diseasesIntracerebral hemorrhagebusiness.industryUltrasoundlcsh:RGeneral Medicinemedicine.diseaseintracerebral hemorrhageCatheterImmunohistochemistrymedicine.symptombusinessNuclear medicinePerfusion030217 neurology & neurosurgeryultrasound-thrombolysisJournal of Clinical Medicine
researchProduct

Pharmacokinetics of new oral anticoagulants: implications for use in routine care

2018

Introduction: Since 2008, new oral anticoagulants (NOACs) have been approved for the prevention of venous thromboembolism (VTE) in patients receiving hip or knee replacement surgery, prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE). Premarketing randomized clinical trials (RCTs) of NOACs demonstrated their non-inferiority in terms of efficacy vs. warfarin (traditional oral anticoagulant–TOA), with lower risk of serious adverse drug reactions, especially cerebral hemorrhages. In clinical practice, pharmacokinetic aspects of NOACs have to be carefully taken into account to …

medicine.medical_treatmentnew oral anticoagulantsAdministration OralKnee replacement030204 cardiovascular system & hematologyToxicologyAdherence Bleeding Interactions New oral anticoagulants Over- and under-dosage Persistence Pharmacokinetics Real World Evidence0302 clinical medicineAtrial Fibrillationover- and underdosage030212 general & internal medicinepharmacokineticStrokeRoutine careRandomized Controlled Trials as Topicnew oral anticoagulantAtrial fibrillationpersistenceVenous ThromboembolismGeneral MedicinePulmonary embolismStrokepharmacokineticsHumanmusculoskeletal diseasesmedicine.medical_specialtyinteractionHemorrhageMedication Adherence03 medical and health sciencesPharmacokineticsmedicineHumansReal World EvidenceIn patientOver- and under-dosagecardiovascular diseasesreal-world evidenceIntensive care medicineAgedPharmacologybusiness.industryAnticoagulantAnticoagulantsinteractionsbleedingmedicine.diseaseAdherencePulmonary EmbolismbusinessVenous thromboembolismExpert Opinion on Drug Metabolism & Toxicology
researchProduct

European guidelines on chronic mesenteric ischaemia - joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy an…

2020

Chronic mesenteric ischaemia is a severe and incapacitating disease, causing complaints of post-prandial pain, fear of eating and weight loss. Even though chronic mesenteric ischaemia may progress to acute mesenteric ischaemia, chronic mesenteric ischaemia remains an underappreciated and undertreated disease entity. Probable explanations are the lack of knowledge and awareness among physicians and the lack of a gold standard diagnostic test. The underappreciation of this disease results in diagnostic delays, underdiagnosis and undertreating of patients with chronic mesenteric ischaemia, potentially resulting in fatal acute mesenteric ischaemia. This guideline provides a comprehensive overvi…

mesenteric artery stentingComputed Tomography AngiographyFOCUSED UPDATEContrast MediaARTERY COMPRESSION SYNDROMEDiseaseGuidelineSettore MED/22 - Chirurgia VascolareSeverity of Illness Indexatherosclerosi0302 clinical medicineIschemiaMesenteric Vascular Occlusionatherosclerosis; coeliac artery release; Median arcuate ligament syndrome; mesenteric arteries; mesenteric artery stenting610 Medicine & healthMesenteric arteriesmesenteric arteriesSocieties MedicalNetherlandsSUPERIOREvidence-Based MedicineGASTRIC EXERCISE TONOMETRYmedicine.diagnostic_testGastroenterologyDUAL ANTIPLATELET THERAPYENHANCED MR-ANGIOGRAPHYEuropeTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisRadiological weaponSURGICAL-TREATMENT030211 gastroenterology & hepatologyRadiologyMedian arcuate ligament syndromeSTENT PLACEMENTmedicine.medical_specialtyANTITHROMBOTIC THERAPYMedian arcuate ligament syndromeRisk Assessment03 medical and health sciencescoeliac artery releasemedicineHumanscardiovascular diseasesIntensive care medicinePatient Care TeamMEDIAN ARCUATE LIGAMENTbusiness.industryGold standardEndoscopyGuidelinemesenteric arteriemedicine.diseaseEndoscopyMesenteric ischemiaMesenteric IschemiaChronic DiseaseInterdisciplinary CommunicationatherosclerosisbusinessMagnetic Resonance Angiography
researchProduct

Acute heart failure due to giant left atrium: remote ECLS implantation for interhospital transfer and bridging to decision

2018

AbstractBackgroundRemote extracorporeal life support (ECLS) implantation and mobile ECLS are increasingly applied to enable the treatment of patients with refractory heart failure at specialized care centers. Giant left atrium (GLA) is a rare cause but may lead to acute and devastating heart failure.Case reportAcute heart failure that gave rise to a prolonged period of out-of-hospital cardiopulmonary resuscitation in a patient who underwent remote ECLS implantation was found to have resulted from a GLA of impressive dimensions. There having no reasonable option for immediate surgical therapy, the patient was successfully bridged to recovery with a view to subsequent heart transplantation.Co…

mobile ECLSHeart transplantationendocrine systemmedicine.medical_specialtyRD1-811business.industrymedicine.medical_treatmentheart failureCase Reportremote ECLS implantationmedicine.diseaseGiant left atriumextracorporeal life supportExtracorporealSurgerygiant left atriumHeart failureLife supportMedicineSurgeryIn patientcardiovascular diseasesCardiopulmonary resuscitationbusinessRefractory heart failureInnovative Surgical Sciences
researchProduct

The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases

2018

International audience; Among the numerous molecules that are being studied for their potential utility as biomarkers of cardiovascular diseases, much interest has been shown in the superfamily of tumor necrosis factor (TNF) receptors. Members of this family include osteoprotegerin (OPG) and its ligands, which are receptor activators of nuclear factor κB ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL). These signals may be expressed and regulated, and their functions could be involved in several physiological and pathological processes. The relationship between bone regulatory proteins and vascular biology has attracted attention, and it has been suggested that OPG may medi…

musculoskeletal diseases0301 basic medicinemedicine.medical_specialtyOsteoporosisInflammationDisease030204 cardiovascular system & hematologyBone remodeling03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemOsteoprotegerinInternal medicinemedicineHumans[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyPharmacology (medical)Vascular CalcificationReceptorPharmacologybiologyChemistryOsteoprotegerinmedicine.disease3. Good health030104 developmental biologyEndocrinologyCardiovascular DiseasesRANKLbiology.proteinTumor necrosis factor alphaBone Remodelingmedicine.symptomPharmacology & Therapeutics
researchProduct

Active compression-decompression cardiopulmonary resuscitation — Instructor and student manual for teaching and training

1996

In an attempt to standardize the teaching and training of active compression-decompression cardiopulmonary resuscitation (ACD-CPR), a group of leading emergency physicians, cardiologists, anesthesiologists, paramedics and nurses with practical, theoretical, educational, and scientific experience in the subject met in June 1995. The group was called The International Working Group of Teaching and Training Active Compression-Decompression CPR. The group was 'born' as a result of the first International Conference of Active Compression-Decompression CPR held in Copenhagen in March 1995. The following paper describes the background, development and text of and ACD-CPR course manual for both stu…

musculoskeletal diseasesMedical educationmedicine.medical_specialtybusiness.industryDecompressionhealth care facilities manpower and servicesmedicine.medical_treatmenteducationMEDLINEInternational working groupEmergency Nursingmedicine.diseaseHealth personnelEmergency medical servicesEmergency MedicinemedicinePhysical therapycardiovascular diseasesMedical emergencyCardiopulmonary resuscitationManuals as TopicCardiology and Cardiovascular Medicinebusinesshealth care economics and organizationsResuscitation
researchProduct

An update on the relationships between rheumatoid arthritis and atherosclerosis

2010

Rheumatoid arthritis is a chronic inflammatory disease. Cardiovascular events are the most important cause of mortality and morbidity in patients with rheumatoid arthritis. Beyond the traditional cardiovascular risk factors, chronic systemic inflammation has been shown to be a crucial factor in atherosclerosis development and progression from endothelial dysfunction to plaque rupture and thrombosis. Many studies have shown that atherosclerosis is not a passive event like accumulation of lipids in the vessel walls; by contrast, it represents an active inflammation of the vessels. Inflammatory cells such as macrophages, monocytes and T cells play important roles in the development of both rhe…

musculoskeletal diseasesT-LymphocytesAtherosclerosis Rheumatoid arthritis Inflammation Cardiovascular risk10265 Clinic for Endocrinology and DiabetologyInflammation610 Medicine & healthComorbiditySystemic inflammationModels BiologicalMonocytes2705 Cardiology and Cardiovascular MedicineArthritis RheumatoidRisk FactorsImmunopathologymedicineHumansEndothelial dysfunctionAutoimmune diseaseInflammationbusiness.industryVascular diseaseMacrophagesmedicine.diseaseAtherosclerosisThrombosisOxidative StressCardiovascular DiseasesRheumatoid arthritisImmunologyDisease Progressionmedicine.symptomInsulin ResistanceCardiology and Cardiovascular Medicinebusiness
researchProduct

CRT-727 Percutaneous Balloon Atrial Septostomy for Direct Left Heart Decompression in Patients on Extra Corporeal Membrane Oxygenation

2014

Severe myocardial dysfunction and added afterload from the Extra Corporeal Membrane Oxygenation (ECMO) arterial cannula may lead to significant rise in left ventricular (LV) end-diastolic and left atrial (LA) pressures. This may result in ischemia, lower likelihood of ventricular recovery and hence

musculoskeletal diseasesmedicine.medical_specialtyPercutaneousbusiness.industryDecompressionIschemiaOxygenationmedicine.diseaseBalloon atrial septostomysurgical procedures operativeAfterloadLeft atrialInternal medicineAnesthesiacardiovascular systemCardiologymedicineIn patientcardiovascular diseasesbusinessCardiology and Cardiovascular MedicineJACC: Cardiovascular Interventions
researchProduct

Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations

2021

Introduction. The frequency, characteristics and clinical implications of Strut fractures (SFs) remain incompletely understood. Methods and results. A total of 185 (160 patients) newer-generation drug-eluting stents (DES) were imaged. SFs were found in 21 DES (11.4%) and were classified in four patterns: one single stacked strut (41%)

musculoskeletal diseasesmedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyArticlecoronary stent03 medical and health sciencesfluids and secretions0302 clinical medicineRestenosisInternal medicineCoronary stentmedicineddc:610cardiovascular diseases030212 general & internal medicineStent thrombosisDevice failureStent restenosisstent thrombosisoptical coherence tomographybusiness.industryRLesion ComplexityGeneral Medicinebioresorbable scaffoldequipment and suppliesmedicine.diseaseThrombosissurgical procedures operativeCardiologyMedicinebusinessBioresorbable scaffoldstent restenosisJournal of Clinical Medicine
researchProduct

Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis

2015

Although statins remain the cornerstone of lipid-lowering therapy for reducing the burden of atherosclerotic vascular disease, their administration has been associated with muscle-related adverse effects, including myalgia and rhabdomyolysis. Such adverse events are probably due to reduced antioxidant defenses associated with fewer intermediate metabolites in the cholesterol synthesis pathway. We hypothesize that the concomitant inhibition of xanthine oxidase via coadministration of allopurinol with statins could diminish reactive oxygen species (ROS)-related muscle damage, which would have in turn have positive effects on both the incidence of muscle-related adverse events and cardiovascul…

myalgiaXanthine OxidaseAntioxidantStatinUbiquinonemedicine.drug_classAllopurinolmedicine.medical_treatmentHypercholesterolemiaAllopurinolPharmacologyRhabdomyolysischemistry.chemical_compoundAnimalsHumansMedicineXanthine oxidaseEnzyme InhibitorsXanthine oxidaseAdverse effectchemistry.chemical_classificationReactive oxygen speciesLipid-lowering drugsbusiness.industryMyalgiamedicine.diseasechemistryCardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase Inhibitorsmedicine.symptomReactive Oxygen SpeciesCardiology and Cardiovascular MedicinebusinessRhabdomyolysisBiomarkersmedicine.drugAtherosclerosis
researchProduct